Patents Assigned to Cutter Laboratories
  • Intravenously injectable immune serum globulin
    Patent number: 4396608
    Abstract: A composition is disclosed which comprises a solution in a pharmaceutically acceptable carrier of an immune serum globulin, said solution having an ionic strength and a pH to maintain the monomer content and the actual and latent anticomplement activity of the immune serum globulin such that the composition is intravenously injectable. Novel methods are disclosed for preparing the above composition.
    Type: Grant
    Filed: August 24, 1981
    Date of Patent: August 2, 1983
    Assignee: Cutter Laboratories
    Inventor: Robert A. Tenold